Dermatology · Vienna, VA
NPI
1386170769
Since 2017
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8301 Old Courthouse Rd
Vienna, VA, 22182
Phone (703) 442-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$327K
4,935 services
Medicare patients, 2024
618
Average age 76
Drug cost, 2024
$333K
1,014 prescriptions
Company payments, 2025
$1.1M
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naiem T Issa was code 17003 (destruction skin lesion), 1,319 times for 211 patients. In total Naiem T Issa billed 4,935 services in 82 codes, and Medicare paid $327K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,319 | 211 | $6.04 | $7,962 |
| 99214 Office E&M - Established | Office | 828 | 464 | $102.10 | $85K |
| 17110 Destruction Skin Lesion | Office | 537 | 365 | $95.72 | $51K |
| 11102 Skin Biopsy | Office | 430 | 336 | $56.66 | $24K |
| 17000 Destruction Skin Lesion | Office | 397 | 272 | $36.49 | $14K |
| 17004 Destruction Skin Lesion | Office | 326 | 252 | $144.36 | $47K |
| 11103 Skin Biopsy | Office | 278 | 154 | $45.40 | $13K |
| 99213 Office E&M - Established | Office | 141 | 118 | $63.22 | $8,913 |
| 99204 Office E&M - New | Office | 134 | 134 | $121.93 | $16K |
| 17111 Destruction Skin Lesion | Office | 54 | 49 | $111.28 | $6,009 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 32 | 26 | $0.74 | $23.72 |
| 11104 Skin Biopsy | Office | 29 | 29 | $113.52 | $3,292 |
| 13121 Wound Repair - All Levels | Office | 26 | 26 | $379.11 | $9,857 |
| 11900 Skin | Office | 25 | 24 | $39.38 | $984 |
| 11602 Skin Lesion Excision | Office | 23 | 21 | $119.94 | $2,759 |
By year: 2022 $69K for 1,000 services; 2023 $208K for 3,240 services; 2024 $327K for 4,935 services.
Medicare prescription drug claims, 2024
In 2024, the drug Naiem T Issa prescribed most often to Medicare patients was Triamcinolone Acetonide, with 257 prescriptions and refills. In total Naiem T Issa wrote 1,014 Medicare prescriptions that cost $333K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 257 | 286 | 222 | $1,763 |
| Clobetasol Propionate Generic | 127 | 142 | 86 | $6,740 |
| Mupirocin Generic | 117 | 122 | 100 | $1,090 |
| Ketoconazole Generic | 87 | 97 | 57 | $1,928 |
| Minoxidil Generic | 58 | 135 | 18 | $886 |
| Klisyri Tirbanibulin | 48 | 48 | 39 | $58K |
| Tacrolimus Generic | 41 | 44 | 27 | $8,113 |
| Clindamycin Phosphate Generic | 38 | 49 | 17 | $867 |
| Doxycycline Hyclate Generic | 28 | 30 | 23 | $243 |
| Jublia Efinaconazole | 23 | 24 | Under 11 | $27K |
| Fluorouracil Generic | 20 | 20 | 17 | $1,447 |
| Prednisone Generic | 15 | 15 | Under 11 | $40.2 |
| Gentamicin Sulfate Generic | 13 | 13 | Under 11 | $510 |
| Opzelura Ruxolitinib Phosphate | 12 | 14 | Under 11 | $34K |
| Hydrocortisone Generic | 11 | 11 | Under 11 | $88.54 |
Brand drugs: 136 claims; generic drugs: 878 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naiem T Issa $1.1M ($1.1M in general payments such as food, travel and fees and $3,200 for research) from 30 companies. The largest payer was Galderma Laboratories, L.P. with $200K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 144 | $200K |
| LEO Pharma Inc. | 146 | $140K |
| UCB, Inc. UCB.BR | 180 | $129K |
| Pfizer Inc. PFE | 62 | $108K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 89 | $81K |
| Incyte Corporation INCY | 89 | $56K |
| Arcutis Biotherapeutics, Inc. ARQT | 37 | $52K |
| Organon LLC OGN | 56 | $52K |
| Novartis Pharmaceuticals Corporation NVS | 46 | $41K |
| Eli Lilly and Company LLY | 21 | $36K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.